Skip to content
Search

Latest Stories

Manisha Koirala joins UK cancer charity Ovacome as ambassador

As part of her voluntary role, Koirala will engage with cancer patients and survivors, sharing her experiences and raising awareness about the disease.

Manisha-Koirala-Ovacome

Ovacome’s CEO, Victoria Clare, welcomed Koirala’s appointment, highlighting the impact her advocacy could have

BOLLYWOOD actor Manisha Koirala has been announced as the new ambassador for Ovacome, the UK-based ovarian cancer support charity.

Koirala, who overcame stage 4 ovarian cancer nearly a decade ago, will work with the organisation to support patients, promote early detection, and address health inequalities.


Each year, around 7,500 people in the UK are diagnosed with ovarian cancer. As part of her voluntary role, Koirala will engage with cancer patients and survivors, sharing her experiences and raising awareness about the disease. Her work will also focus on improving knowledge of symptoms to help with earlier diagnoses.

Speaking about her new role, Koirala said, “I want to use my voice to support cancer patients and raise awareness about the need for equitable healthcare access and the importance of knowing the signs and symptoms of ovarian cancer. Having faced cancer myself, I know how isolating and challenging the journey can be.”

Ovacome’s CEO, Victoria Clare, welcomed Koirala’s appointment, highlighting the impact her advocacy could have. “Manisha’s decision to share her own experience and challenge the stigma associated with the disease is deeply inspiring. We look forward to working together to improve equitable access to diagnosis and treatment,” Clare said.

Ovacome supporter Preeti added that Koirala’s global influence, particularly in diverse communities, could help break stigmas surrounding ovarian cancer and encourage earlier diagnosis.

Koirala, known for her roles in Bollywood and her latest Netflix series Heeramandi, has previously shared her journey in her memoir, Healed. She was also honoured in British Parliament last year for her resilience and contributions to cinema.

Ovacome offers support services, including a helpline, online forums, and awareness campaigns. More information can be found on their website.

More For You

Asian community

Menopause is a universal transition - one every woman will experience in her lifetime

iStock

Breaking the silence: Why Asian women must talk about menopause

Kiran Singh

For many women in the Asian community, the journey through perimenopause and menopause is still shrouded in silence, confusion, and, at times, shame. It’s often seen as something we just have to “put up with” quietly, as though struggling through it alone is a badge of honour. But the truth is, menopause is a universal transition - one every woman will experience in her lifetime - and it is time we start talking about it, especially within our cultural communities where silence often masks suffering.

We all go through it - so why don’t we talk about it?

Menopause doesn’t arrive overnight. For most women, it begins subtly during perimenopause, which can start as early as your late 30s or early 40s and last for several years. According to the NHS and the National Institute for Health and Care Excellence (NICE), over 30 recognised symptoms of perimenopause range from hot flushes and night sweats to anxiety, low mood, brain fog, and joint pain.

Keep ReadingShow less
Great guide to building healthy eating habits

Good nutrition is the foundation of an active lifestyle

Great guide to building healthy eating habits

Nesreen G and Jayeeta Dutta

PHYSICAL exercise is important when it comes to fitness, but what we fuel our body with plays an equally vital role in achieving sustainable results.

The key to long-term fitness success is developing mindful eating habits that nourish the body and soul, enhance performance and help maintain a healthy lifestyle. This does not necessarily mean following a restrictive diet or complicated meal plans. It is about finding a sustainable balance that works for you.

Keep ReadingShow less
The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
MRI

Individuals with certain metabolic conditions may be more prone to this process

Getty

MRI injection linked to rare deadly health risk, study finds

A new study has raised concerns over the use of a common chemical injected during MRI scans, suggesting it may contribute to a potentially fatal complication in rare cases.

Researchers from the University of New Mexico have found that gadolinium – a toxic rare earth metal used in MRI contrast agents – can interact with oxalic acid found in many foods to form nanoparticles in human tissues. These particles could potentially lead to serious health problems affecting organs such as the kidneys.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less